Evidence map›Paper›PMID 40559326›Full record

ArticleNeurology international2025

The C/C Genotype of the C-1019G (rs6295) Polymorphism of the 5-HT1A Receptor Gene Is Associated with Lower Susceptibility to Depressive Symptoms in a Rural Population in Mexico.

Margarita Hernandez-Mixteco, Olga Lidia Valenzuela, Cecilia Luz Balderas-Vazquez, Paola Castillo-Juárez, Sandra Rivera-Gutiérrez, Rocío Liliana García-Reyes, Gilberto Cornejo-Estudillo, Ricardo Jiovanni Soria-Herrera, Moises León-Juárez, Addy Cecilia Helguera-Repetto and 4 more

Abstract read
In one paragraph

Article in Neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Association of the C-1019G (rs6295) Polymorphism of theDiseases (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Margarita Hernandez-MixtecoDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.
Olga Lidia ValenzuelaFacultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Veracruz 94340, Mexico.
Cecilia Luz Balderas-VazquezCoordinación de Ingeniería Biomédica, Universidad Anáhuac, Campus Córdoba, Veracruz 94500, Mexico.ORCID 0000-0001-7418-2482
Paola Castillo-JuárezDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.ORCID 0000-0001-5086-3902
Sandra Rivera-GutiérrezDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.
Rocío Liliana García-ReyesDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.ORCID 0009-0001-8399-6899
Gilberto Cornejo-EstudilloEscuela José Ma. Pastrana. Secretaría de Educación Pública, Yecapixtla, Morelos 62829, Mexico.
Ricardo Jiovanni Soria-HerreraFacultad de Químico Farmacobiología, Universidad Michoacana de San Nicolas de Hidalgo, Morelia Michoacán 58240, Mexico.ORCID 0009-0006-9997-7584
Moises León-JuárezDepartamento de Inmunobioquimica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México 11000, Mexico.ORCID 0000-0002-5726-5953
Addy Cecilia Helguera-RepettoDepartamento de Inmunobioquimica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México 11000, Mexico.
Daniel Valencia-TrujilloDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.ORCID 0000-0002-7436-3782
Victoria Campos-PeñaLaboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Ciudad de México 14269, Mexico.ORCID 0000-0001-8282-7543
Eliud Alfredo Garcia-MontalvoFacultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Veracruz 94340, Mexico.ORCID 0000-0002-8393-206X
Jorge Francisco Cerna-CortésDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.ORCID 0000-0002-4350-9507

Funding

Secretaria de Investigación y Posgrado (SIP) 20251005
6 · The paper itself

Abstract

backgroundDepression is one of the most prevalent mental health disorders worldwide, affecting a significant proportion of the global population. Its etiology is complex and influenced by the interaction of environmental factors and genetic variations. In Mexico, it has been reported that 41.3% of the population exhibits depressive symptoms. Previous studies have suggested that susceptibility to depression may be associated with the C-1019G (rs6295) polymorphism in the serotonin 1A (5-HT1A) receptor gene.

objectiveIn this study, we aimed to evaluate the association between the C-1019G polymorphism and depressive symptoms in a rural Mexican population.

methodsUsing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), we examined the effect of C-1019G on depression symptoms, as evaluated by the Beck Depression Inventory. Data were obtained from 83 volunteers; individuals with depressive symptoms and those with a healthy mood were compared.

resultsThe results showed that the homozygous C/C genotype was found significantly more frequently in the control group than in individuals with depressive symptoms, particularly among men, and is thus associated with a decreased risk of depressive symptomatology.

conclusionsThe C/C genotype could protect against susceptibility to developing depressive symptoms in a rural population in Mexico.

Indexed as

5-HT1A receptor geneC-1019G polymorphismdepression symptomsMexican population

Identifiers

PMID40559326
PMCPMC12196349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.